Abiopharma

Brennan Aoife 🟢 acquired 700.0K shares (1 derivative) of Climb Bio, Inc. (CLYM) at $3.81 ($2.7M) Transaction Date: Jan 06, 2026 | Filing ID: 007670

FRATES JAMES M 🔴 sold 3.3K shares of Amylyx Pharmaceuticals, Inc. (AMLX) at $11.11 Transaction Date: Jan 06, 2026 | Filing ID: 007669

Cohen Joshua B 🔴 sold 7.7K shares of Amylyx Pharmaceuticals, Inc. (AMLX) at $11.09 Transaction Date: Jan 06, 2026 | Filing ID: 007666

ALTSCHULLER Susan 🟢 acquired 142.5K shares (1 derivative) of Climb Bio, Inc. (CLYM) at $3.81 Transaction Date: Jan 06, 2026 | Filing ID: 007665

Klee Justin B. 🔴 sold 7.7K shares of Amylyx Pharmaceuticals, Inc. (AMLX) at $11.09 Transaction Date: Jan 06, 2026 | Filing ID: 007664

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Driscoll Cindy 🟢 acquired 100.0K shares (1 derivative) of Climb Bio, Inc. (CLYM) at $3.81 Transaction Date: Jan 06, 2026 | Filing ID: 007662

Director SUN ANTHONY 🟡 adjusted position in 99.2K shares (7 derivative) of COGNEX CORP (CGNX) at $56.44 ($5.1M) Transaction Date: Jan 08, 2026 | Filing ID: 000002

Icecure Medical Ltd (ICCM) Files Form 6-K

RENTON HOLLINGS 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer